Please login to the form below

Not currently logged in


This page shows the latest HPV news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

The firm has now announced it is cutting back spending on axalimogene filolisbac (AXAL) and will seek a new partner for the therapy in most human papillomavirus (HPV)-associated cancers, including

Latest news

More from news
Approximately 5 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • Advancing women in healthcare Advancing women in healthcare

    She is especially proud of working to reduce the manufacturing costs of vaccines for diseases like human papillomavirus (HPV) and rotavirus, with the aim of these being more widely available in

  • Immunisation politicised Immunisation politicised

    sexually transmitted human papilloma virus (HPV), including strains that lead to cervical cancer. ... to do so, Austria became a 'European frontrunner' in gender-neutral HPV vaccination.

  • Deal Watch December 2015 Deal Watch December 2015

    200. Bavarian Nordic (DK). Janssen. Collaboration, licence. Vaccine platform technology for development of treatment for cancers induced by HPV.

  • Pharma deals in August 2015 Pharma deals in August 2015

    virus. INO-3112 generates killer T-cell responses to HPV 16 and 18 driven tumours and is in phase I / II clinical studies for cervical and head and neck cancers.

  • Mapping KOL relationships Mapping KOL relationships

    In HPV, for example, influencers include virologists, immunologists, pathologists and epidemiologists.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....